Translational Development Acquisition Corp.

TDAC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Assets
Cash & Equivalents$0$0$0
Short-Term Investments$0$0$0
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$0$0$0
Total Curr. Assets$1$0$0
Property Plant & Equip (Net)$0$0$0
Goodwill$9,061,675$0$0
Intangibles$12,569,165$0$0
Long-Term Investments$174$0$0
Tax Assets$0$0$0
Other NC Assets-$21,630,840$0$0
Total NC Assets$174$0$0
Other Assets$0$0$0
Total Assets$175$0$0
Liabilities
Payables$0$0$0
Short-Term Debt$6,110,777$0$0
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.-$6,110,777$0$0
Total Curr. Liab.$0$1$0
LT Debt$0$0$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$6$0$0
Total NC Liab.$6$0$0
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$6$1$0
Equity
Pref Stock$0$0$0
Common Stock$18,327$0$0
Retained Earnings-$6-$1-$0
AOCI$16,880$0$0
Other Equity-$35,033$0$0
Total Equity$169-$1-$0
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$175$0$0
Net Debt$6,110,777$0$0